Connection

NADER EL-MALLAWANY to HIV Infections

This is a "connection" page, showing publications NADER EL-MALLAWANY has written about HIV Infections.
Connection Strength

2.348
  1. Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. JCI Insight. 2023 Nov 22; 8(22).
    View in: PubMed
    Score: 0.375
  2. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania. HIV Med. 2023 06; 24(6):664-675.
    View in: PubMed
    Score: 0.353
  3. Long-term outcomes for children and adolescents with Kaposi sarcoma. HIV Med. 2022 02; 23(2):197-203.
    View in: PubMed
    Score: 0.324
  4. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions. Int J Cancer. 2019 01 01; 144(1):110-116.
    View in: PubMed
    Score: 0.264
  5. Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi. Clin Infect Dis. 2017 03 15; 64(6):818-819.
    View in: PubMed
    Score: 0.236
  6. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335.
    View in: PubMed
    Score: 0.222
  7. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries. Int J STD AIDS. 2020 07; 31(8):724-734.
    View in: PubMed
    Score: 0.074
  8. Navigating the heterogeneous landscape of pediatric Kaposi sarcoma. Cancer Metastasis Rev. 2019 12; 38(4):749-758.
    View in: PubMed
    Score: 0.071
  9. Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. Clin Infect Dis. 2019 11 13; 69(11):2022-2025.
    View in: PubMed
    Score: 0.071
  10. Impact of Protease Inhibitors on HIV-Associated Kaposi Sarcoma Incidence: A Systematic Review. J Acquir Immune Defic Syndr. 2018 10 01; 79(2):141-148.
    View in: PubMed
    Score: 0.066
  11. Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol. 2018 09; 4:1-7.
    View in: PubMed
    Score: 0.062
  12. Lessons From Pediatric HIV: A Case for Curative Intent in Pediatric Cancer in LMICs. Pediatrics. 2017 10; 140(4).
    View in: PubMed
    Score: 0.061
  13. Hodgkin lymphoma, HIV, and Epstein-Barr virus in Malawi: Longitudinal results from the Kamuzu Central Hospital Lymphoma study. Pediatr Blood Cancer. 2017 05; 64(5).
    View in: PubMed
    Score: 0.057
  14. Tumoral bacillary angiomatosis in a child with human immunodeficiency virus. JAMA Dermatol. 2014 Sep; 150(9):1015-6.
    View in: PubMed
    Score: 0.050
  15. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Aug; 60(8):1274-80.
    View in: PubMed
    Score: 0.045
  16. Prospective study of Burkitt lymphoma treatment in adolescents and adults in Malawi. Blood Adv. 2019 02 26; 3(4):612-620.
    View in: PubMed
    Score: 0.017
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.